Dov Gavish

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

Donald S. Silverberg, Dov Wexler, Miriam Blum et al. · Journal of the American College of Cardiology · 2000 · 726 citations

Anemia, Subcutaneous Erythropoietin, Heart Failure +12

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

Gerhard M. Kostner, Dov Gavish, Beate Leopold et al. · Circulation · 1989 · 339 citations

Metabolic Syndrome, Oxysterol, Cardiovascular Disease +11

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

S Eisenberg, Dov Gavish, Y Oschry et al. · Journal of Clinical Investigation · 1984 · 295 citations · Full text

Bezafibrate Treatment, Hyperlipidemia, High Density Lipoproteins +19

Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.

Dov Gavish, Neal Azrolan, J L Breslow · Journal of Clinical Investigation · 1989 · 156 citations · Full text

Vascular Disease, Genetics, Molecular Biology +20

Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy.

Yosef Kleinman, S Eisenberg, Y Oschry et al. · Journal of Clinical Investigation · 1985 · 123 citations · Full text